Market closed
STAAR/$STAA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About STAAR
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
Ticker
$STAA
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,157
Website
STAAR Metrics
BasicAdvanced
$833M
-
-$0.41
0.63
-
Price and volume
Market cap
$833M
Beta
0.63
52-week high
$49.86
52-week low
$13.50
Average daily volume
1.1M
Financial strength
Current ratio
5.233
Quick ratio
4.406
Long term debt to equity
8.76
Total debt to equity
9.751
Management effectiveness
Return on assets (TTM)
-1.58%
Return on equity (TTM)
-5.16%
Valuation
Price to revenue (TTM)
2.643
Price to book
2.09
Price to tangible book (TTM)
2.1
Price to free cash flow (TTM)
-108.192
Growth
Revenue change (TTM)
-2.64%
Earnings per share change (TTM)
-195.66%
3-year revenue growth (CAGR)
10.85%
3-year earnings per share growth (CAGR)
-9.77%
What the Analysts think about STAAR
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for STAAR stock.
STAAR Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
STAAR Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
STAAR News
AllArticlesVideos
Tilman Fertitta, Carl Icahn, and More Insiders Return to the Buy Window
24/7 Wall Street·1 week ago
STAAR Surgical Announces Realignment of Leadership Structure
Business Wire·1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA
Accesswire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for STAAR stock?
STAAR (STAA) has a market cap of $833M as of April 20, 2025.
What is the P/E ratio for STAAR stock?
The price to earnings (P/E) ratio for STAAR (STAA) stock is 0 as of April 20, 2025.
Does STAAR stock pay dividends?
No, STAAR (STAA) stock does not pay dividends to its shareholders as of April 20, 2025.
When is the next STAAR dividend payment date?
STAAR (STAA) stock does not pay dividends to its shareholders.
What is the beta indicator for STAAR?
STAAR (STAA) has a beta rating of 0.63. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.